SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4h1g'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	4 / 6	VAL A-362 VAL A-320 ILE A-310 ASN A-103	None	0.89A	1e06A-4h1gA: undetectable	1e06A-4h1gA: 12.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSH_A_MK1A401_2 (HIV-II PROTEASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	6 / 9	ALA A -94 ILE A-361 VAL A-335 ILE A-368 ILE A-310 ILE A-311	None	1.43A	1hshB-4h1gA: undetectable	1hshB-4h1gA: 10.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JG2_A_ADNA500_1 (PROTEIN-L-ISOASPARTA TE O-METHYLTRANSFERASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	GLY A 485 ILE A 564 THR A 527 VAL A 525 LEU A 499	None	0.97A	1jg2A-4h1gA: undetectable	1jg2A-4h1gA: 15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SH9_B_RITB301_2 (POL POLYPROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 10	ASP A 568 ASP A 529 ILE A 530 ILE A 528 ILE A 488	None	0.99A	1sh9B-4h1gA: undetectable	1sh9B-4h1gA: 8.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WOP_A_FFOA2888_0 (AMINOMETHYLTRANSFERA SE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 10	LEU A-178 LEU A-175 ILE A-209 GLU A-217 LEU A-219	None None None MTT A 701 (-3.2A) None	1.25A	1wopA-4h1gA: undetectable	1wopA-4h1gA: 19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BR4_D_SAMD301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	3 / 3	LYS A 645 ASP A-163 ASP A 515	None	0.89A	2br4D-4h1gA: undetectable	2br4D-4h1gA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXQ_A_P1ZA2002_1 (SERUM ALBUMIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	HIS A 557 LEU A 498 ILE A 488 ILE A 495 ALA A 494	None	0.99A	2bxqA-4h1gA: undetectable	2bxqA-4h1gA: 21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6O_A_SAMA500_0 (HYPOTHETICAL PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	4 / 7	ASP A-173 VAL A-174 ALA A -20 THR A 576	None	0.90A	2q6oA-4h1gA: undetectable	2q6oA-4h1gA: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q8H_A_TF4A438_1 ([PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	4 / 6	LEU A 389 TYR A 375 ILE A 660 ILE A 409	None	0.97A	2q8hA-4h1gA: undetectable	2q8hA-4h1gA: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	ALA A-106 LEU A -90 PHE A -91 VAL A -77 GLY A-354	None	1.09A	2ve3A-4h1gA: undetectable	2ve3A-4h1gA: 20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZLC_A_VDXA500_1 (VITAMIN D3 RECEPTOR)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	LEU A 423 SER A 463 SER A 430 LEU A 644 LEU A 589	None	1.24A	2zlcA-4h1gA: undetectable	2zlcA-4h1gA: 17.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	4 / 7	VAL A-260 GLY A -70 PRO A-141 LYS A -65	None	0.71A	3bjwC-4h1gA: undetectable	3bjwC-4h1gA: 9.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_A_BEZA302_0 (DISULFIDE INTERCHANGE PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	4 / 6	PRO A-244 LEU A-223 ALA A-147 PRO A-245	None	1.33A	3gv1A-4h1gA: undetectable 3gv1C-4h1gA: undetectable	3gv1A-4h1gA: 11.42 3gv1C-4h1gA: 11.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_B_BEZB301_0 (DISULFIDE INTERCHANGE PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	4 / 6	LEU A-223 ALA A-147 PRO A-245 PRO A-244	None	1.32A	3gv1A-4h1gA: undetectable 3gv1B-4h1gA: undetectable	3gv1A-4h1gA: 11.42 3gv1B-4h1gA: 11.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	11 / 12	ASP A-356 LYS A-355 GLU A-326 GLU A-325 ALA A-307 ASP A-305 ARG A-304 GLU A-259 PRO A-216 TRP A-140 TYR A -29	MTT A 701 (-2.9A) MTT A 701 (-2.8A) MTT A 701 (-3.1A) MTT A 701 (-3.4A) MTT A 701 (-3.2A) MTT A 701 (-2.7A) MTT A 701 (-3.8A) MTT A 701 (-3.0A) MTT A 701 (-3.5A) MTT A 701 (-4.3A) MTT A 701 (-4.6A)	0.18A	3jyrA-4h1gA: 63.0	3jyrA-4h1gA: 47.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	6 / 7	ASN A-358 TRP A-308 GLU A-217 TYR A-215 MET A -40 TRP A -30	MTT A 701 ( 4.8A) MTT A 701 (-4.5A) MTT A 701 (-3.2A) MTT A 701 (-3.8A) MTT A 701 ( 4.1A) MTT A 701 (-3.8A)	0.25A	3jyrA-4h1gA: 63.0	3jyrA-4h1gA: 47.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	6 / 7	ASN A-358 TRP A-308 TYR A-215 MET A -40 TRP A -30 ARG A -26	MTT A 701 ( 4.8A) MTT A 701 (-4.5A) MTT A 701 (-3.8A) MTT A 701 ( 4.1A) MTT A 701 (-3.8A) MTT A 701 (-3.9A)	0.59A	3jyrA-4h1gA: 63.0	3jyrA-4h1gA: 47.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K4V_D_ROCD201_1 (HIV-1 PROTEASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	LEU A 625 VAL A 680 ILE A 587 VAL A 621 ILE A 622	None	1.03A	3k4vC-4h1gA: undetectable	3k4vC-4h1gA: 9.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KW2_A_ADNA300_1 (PROBABLE R-RNA METHYLTRANSFERASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 11	ILE A 530 GLY A 485 SER A 463 LEU A 464 ALA A 536	None	1.21A	3kw2A-4h1gA: undetectable	3kw2A-4h1gA: 16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KW2_B_ADNB300_1 (PROBABLE R-RNA METHYLTRANSFERASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 11	ILE A 530 GLY A 485 SER A 463 LEU A 464 ALA A 536	None	1.25A	3kw2B-4h1gA: undetectable	3kw2B-4h1gA: 16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXI_A_CAMA423_0 (CYTOCHROME P450)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 10	THR A 654 THR A 641 LEU A 618 GLY A 619 VAL A 633	None	1.32A	3lxiA-4h1gA: undetectable	3lxiA-4h1gA: 21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	VAL A-174 LEU A-210 GLY A-183 ALA A-182 LEU A -9	None	0.98A	3n8yB-4h1gA: undetectable	3n8yB-4h1gA: 22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDU_D_ROCD100_1 (PROTEASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	LEU A 625 VAL A 680 ILE A 587 VAL A 621 ILE A 622	None	1.01A	3nduC-4h1gA: undetectable	3nduC-4h1gA: 8.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PGH_A_FLPA701_1 (CYCLOOXYGENASE-2)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	VAL A -27 LEU A-210 GLY A-183 ALA A-182 LEU A -9	None	1.32A	3pghA-4h1gA: undetectable	3pghA-4h1gA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	PHE A-214 GLY A -70 LEU A -71 GLU A-259 ALA A-139	None None None MTT A 701 (-3.0A) None	0.85A	3tbgB-4h1gA: undetectable	3tbgB-4h1gA: 22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	PHE A-214 GLY A -70 LEU A -71 GLU A-259 ALA A-139	None None None MTT A 701 (-3.0A) None	0.83A	3tbgD-4h1gA: undetectable	3tbgD-4h1gA: 22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	ALA A-139 TYR A-353 TYR A-160 ASN A-136 GLY A-142	None	1.36A	3vwqA-4h1gA: undetectable	3vwqA-4h1gA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W67_C_VIVC301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 12	LEU A 569 SER A 430 PHE A 420 LEU A 586 VAL A 438	None	1.10A	3w67C-4h1gA: undetectable	3w67C-4h1gA: 18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W68_A_VIVA301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 12	LEU A 569 SER A 430 PHE A 420 LEU A 586 VAL A 438	None	1.19A	3w68A-4h1gA: undetectable	3w68A-4h1gA: 18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZJQ_A_NCAA300_0 (PROTOGLOBIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 7	VAL A 438 PHE A 657 VAL A 419 PHE A 420 ILE A 427	None	1.14A	3zjqA-4h1gA: undetectable	3zjqA-4h1gA: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZJQ_B_NCAB300_0 (PROTOGLOBIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 7	VAL A 438 PHE A 657 VAL A 419 PHE A 420 ILE A 427	None	1.13A	3zjqB-4h1gA: undetectable	3zjqB-4h1gA: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AX8_A_SAMA1474_1 (WBDD)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	4 / 6	ARG A 349 ASP A 432 GLU A 473 LEU A 426	None	1.40A	4ax8A-4h1gA: undetectable	4ax8A-4h1gA: 21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C9K_A_CAMA424_0 (CYTOCHROME P450)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 9	THR A 654 THR A 641 LEU A 618 GLY A 619 VAL A 633	None	1.28A	4c9kA-4h1gA: undetectable	4c9kA-4h1gA: 21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C9P_A_CAMA423_0 (CYTOCHROME P450)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 9	THR A 654 THR A 641 LEU A 618 GLY A 619 VAL A 633	None	1.34A	4c9pA-4h1gA: undetectable	4c9pA-4h1gA: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DFR_B_MTXB162_1 (DIHYDROFOLATE REDUCTASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	ILE A 490 ALA A 590 LEU A 618 LEU A 644 ILE A 564	None	1.08A	4dfrB-4h1gA: undetectable	4dfrB-4h1gA: 13.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K39_A_SAMA504_0 (ANAEROBIC SULFATASE-MATURATING ENZYME)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 12	PHE A 565 ASN A 435 SER A 430 LEU A 431 ILE A 467	None	1.33A	4k39A-4h1gA: undetectable	4k39A-4h1gA: 19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LF7_A_PARA1817_1 (16S RRNA RIBOSOMAL PROTEIN S9 RIBOSOMAL PROTEIN S10)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	3 / 3	TYR A -29 ARG A-304 SER A -33	MTT A 701 (-4.6A) MTT A 701 (-3.8A) None	1.11A	4lf7I-4h1gA: undetectable 4lf7J-4h1gA: undetectable	4lf7I-4h1gA: 10.81 4lf7J-4h1gA: 9.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LF8_A_PARA1817_1 (16S RRNA RIBOSOMAL PROTEIN S9 RIBOSOMAL PROTEIN S10)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	3 / 3	TYR A -29 ARG A-304 SER A -33	MTT A 701 (-4.6A) MTT A 701 (-3.8A) None	1.11A	4lf8I-4h1gA: undetectable 4lf8J-4h1gA: undetectable	4lf8I-4h1gA: 10.81 4lf8J-4h1gA: 9.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	4 / 5	ASN A-103 ALA A-319 GLY A-314 ASP A-356	None None None MTT A 701 (-2.9A)	0.97A	4n48A-4h1gA: undetectable	4n48A-4h1gA: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 9	ALA A-106 ALA A-265 LEU A-267 LEU A-108 VAL A-109	None	1.11A	4or0B-4h1gA: undetectable	4or0B-4h1gA: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JH7_B_6K9B503_1 (TUBULIN ALPHA-1B CHAIN TUBULIN BETA-2B CHAIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	4 / 7	GLU A 422 ASN A 626 ILE A 622 VAL A 350	None	0.96A	5jh7C-4h1gA: undetectable	5jh7C-4h1gA: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	GLN A-321 ALA A-101 GLY A-316 THR A-317 ALA A-318	None	1.18A	5l66H-4h1gA: undetectable 5l66I-4h1gA: undetectable	5l66H-4h1gA: 15.17 5l66I-4h1gA: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	5 / 12	GLN A-321 ALA A-101 GLY A-316 THR A-317 ALA A-318	None	1.18A	5l66V-4h1gA: undetectable 5l66W-4h1gA: undetectable	5l66V-4h1gA: 15.17 5l66W-4h1gA: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M0O_C_EPAC502_1 (TERMINAL OLEFIN-FORMING FATTY ACID DECARBOXYLASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Candida albicans; Escherichia coli)	4 / 8	ILE A 530 PRO A 533 ALA A 536 PHE A 565	None	0.70A	5m0oC-4h1gA: undetectable	5m0oC-4h1gA: 20.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA603_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	3 / 3	TYR A-215 ASN A-143 LEU A-257	MTT A 701 (-3.8A) None None	0.79A	6b58A-4h1gA: undetectable	6b58A-4h1gA: 22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BM5_A_SAMA1301_0 (METHIONINE SYNTHASE)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 11	PRO A-237 GLU A-240 PRO A-116 ALA A-207 PRO A-211	None	1.42A	6bm5A-4h1gA: undetectable	6bm5A-4h1gA: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ECX_A_SAMA1301_0 (STIE PROTEIN)	4h1g	MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN (Escherichia coli; Candida albicans)	5 / 12	LEU A -95 GLY A-346 VAL A-335 LEU A-363 ILE A-361	None	1.00A	6ecxA-4h1gA: undetectable	6ecxA-4h1gA: 17.49

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",4,"VAL A-362;VAL A-320;ILE A-310;ASN A-103","None","0.89A","1e06A-4h1gA:undetectable","1e06A-4h1gA:12.48"],["1HSH_A_MK1A401_2","HIV-II PROTEASE;HIV-II PROTEASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",6,"ALA A -94;ILE A-361;VAL A-335;ILE A-368;ILE A-310;ILE A-311","None","1.43A","1hshB-4h1gA:undetectable","1hshB-4h1gA:10.89"],["1JG2_A_ADNA500_1","PROTEIN-L-ISOASPARTATE O-METHYLTRANSFERASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"GLY A 485;ILE A 564;THR A 527;VAL A 525;LEU A 499","None","0.97A","1jg2A-4h1gA:undetectable","1jg2A-4h1gA:15.69"],["1SH9_B_RITB301_2","POL POLYPROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"ASP A 568;ASP A 529;ILE A 530;ILE A 528;ILE A 488","None","0.99A","1sh9B-4h1gA:undetectable","1sh9B-4h1gA:8.64"],["1WOP_A_FFOA2888_0","AMINOMETHYLTRANSFERASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"LEU A-178;LEU A-175;ILE A-209;GLU A-217;LEU A-219","None;None;None;MTT A 701 (-3.2A);None","1.25A","1wopA-4h1gA:undetectable","1wopA-4h1gA:19.48"],["2BR4_D_SAMD301_1","CEPHALOSPORIN HYDROXYLASE CMCI","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",3,"LYS A 645;ASP A-163;ASP A 515","None","0.89A","2br4D-4h1gA:undetectable","2br4D-4h1gA:14.97"],["2BXQ_A_P1ZA2002_1","SERUM ALBUMIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"HIS A 557;LEU A 498;ILE A 488;ILE A 495;ALA A 494","None","0.99A","2bxqA-4h1gA:undetectable","2bxqA-4h1gA:21.76"],["2Q6O_A_SAMA500_0","HYPOTHETICAL PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",4,"ASP A-173;VAL A-174;ALA A -20;THR A 576","None","0.90A","2q6oA-4h1gA:undetectable","2q6oA-4h1gA:19.50"],["2Q8H_A_TF4A438_1","[PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",4,"LEU A 389;TYR A 375;ILE A 660;ILE A 409","None","0.97A","2q8hA-4h1gA:undetectable","2q8hA-4h1gA:21.03"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"ALA A-106;LEU A -90;PHE A -91;VAL A -77;GLY A-354","None","1.09A","2ve3A-4h1gA:undetectable","2ve3A-4h1gA:20.67"],["2ZLC_A_VDXA500_1","VITAMIN D3 RECEPTOR","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"LEU A 423;SER A 463;SER A 430;LEU A 644;LEU A 589","None","1.24A","2zlcA-4h1gA:undetectable","2zlcA-4h1gA:17.17"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",4,"VAL A-260;GLY A -70;PRO A-141;LYS A -65","None","0.71A","3bjwC-4h1gA:undetectable","3bjwC-4h1gA:9.64"],["3GV1_A_BEZA302_0","DISULFIDE INTERCHANGE PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",4,"PRO A-244;LEU A-223;ALA A-147;PRO A-245","None","1.33A","3gv1A-4h1gA:undetectable;3gv1C-4h1gA:undetectable","3gv1A-4h1gA:11.42;3gv1C-4h1gA:11.42"],["3GV1_B_BEZB301_0","DISULFIDE INTERCHANGE PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",4,"LEU A-223;ALA A-147;PRO A-245;PRO A-244","None","1.32A","3gv1A-4h1gA:undetectable;3gv1B-4h1gA:undetectable","3gv1A-4h1gA:11.42;3gv1B-4h1gA:11.42"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",11,"ASP A-356;LYS A-355;GLU A-326;GLU A-325;ALA A-307;ASP A-305;ARG A-304;GLU A-259;PRO A-216;TRP A-140;TYR A -29","MTT A 701 (-2.9A);MTT A 701 (-2.8A);MTT A 701 (-3.1A);MTT A 701 (-3.4A);MTT A 701 (-3.2A);MTT A 701 (-2.7A);MTT A 701 (-3.8A);MTT A 701 (-3.0A);MTT A 701 (-3.5A);MTT A 701 (-4.3A);MTT A 701 (-4.6A)","0.18A","3jyrA-4h1gA:63.0","3jyrA-4h1gA:47.16"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",6,"ASN A-358;TRP A-308;GLU A-217;TYR A-215;MET A -40;TRP A -30","MTT A 701 ( 4.8A);MTT A 701 (-4.5A);MTT A 701 (-3.2A);MTT A 701 (-3.8A);MTT A 701 ( 4.1A);MTT A 701 (-3.8A)","0.25A","3jyrA-4h1gA:63.0","3jyrA-4h1gA:47.16"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",6,"ASN A-358;TRP A-308;TYR A-215;MET A -40;TRP A -30;ARG A -26","MTT A 701 ( 4.8A);MTT A 701 (-4.5A);MTT A 701 (-3.8A);MTT A 701 ( 4.1A);MTT A 701 (-3.8A);MTT A 701 (-3.9A)","0.59A","3jyrA-4h1gA:63.0","3jyrA-4h1gA:47.16"],["3K4V_D_ROCD201_1","HIV-1 PROTEASE;HIV-1 PROTEASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"LEU A 625;VAL A 680;ILE A 587;VAL A 621;ILE A 622","None","1.03A","3k4vC-4h1gA:undetectable","3k4vC-4h1gA:9.21"],["3KW2_A_ADNA300_1","PROBABLE R-RNA METHYLTRANSFERASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"ILE A 530;GLY A 485;SER A 463;LEU A 464;ALA A 536","None","1.21A","3kw2A-4h1gA:undetectable","3kw2A-4h1gA:16.02"],["3KW2_B_ADNB300_1","PROBABLE R-RNA METHYLTRANSFERASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"ILE A 530;GLY A 485;SER A 463;LEU A 464;ALA A 536","None","1.25A","3kw2B-4h1gA:undetectable","3kw2B-4h1gA:16.02"],["3LXI_A_CAMA423_0","CYTOCHROME P450","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"THR A 654;THR A 641;LEU A 618;GLY A 619;VAL A 633","None","1.32A","3lxiA-4h1gA:undetectable","3lxiA-4h1gA:21.70"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"VAL A-174;LEU A-210;GLY A-183;ALA A-182;LEU A  -9","None","0.98A","3n8yB-4h1gA:undetectable","3n8yB-4h1gA:22.28"],["3NDU_D_ROCD100_1","PROTEASE;PROTEASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"LEU A 625;VAL A 680;ILE A 587;VAL A 621;ILE A 622","None","1.01A","3nduC-4h1gA:undetectable","3nduC-4h1gA:8.95"],["3PGH_A_FLPA701_1","CYCLOOXYGENASE-2","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"VAL A -27;LEU A-210;GLY A-183;ALA A-182;LEU A  -9","None","1.32A","3pghA-4h1gA:undetectable","3pghA-4h1gA:22.32"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"PHE A-214;GLY A -70;LEU A -71;GLU A-259;ALA A-139","None;None;None;MTT A 701 (-3.0A);None","0.85A","3tbgB-4h1gA:undetectable","3tbgB-4h1gA:22.01"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"PHE A-214;GLY A -70;LEU A -71;GLU A-259;ALA A-139","None;None;None;MTT A 701 (-3.0A);None","0.83A","3tbgD-4h1gA:undetectable","3tbgD-4h1gA:22.01"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"ALA A-139;TYR A-353;TYR A-160;ASN A-136;GLY A-142","None","1.36A","3vwqA-4h1gA:undetectable","3vwqA-4h1gA:19.46"],["3W67_C_VIVC301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"LEU A 569;SER A 430;PHE A 420;LEU A 586;VAL A 438","None","1.10A","3w67C-4h1gA:undetectable","3w67C-4h1gA:18.19"],["3W68_A_VIVA301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"LEU A 569;SER A 430;PHE A 420;LEU A 586;VAL A 438","None","1.19A","3w68A-4h1gA:undetectable","3w68A-4h1gA:18.19"],["3ZJQ_A_NCAA300_0","PROTOGLOBIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"VAL A 438;PHE A 657;VAL A 419;PHE A 420;ILE A 427","None","1.14A","3zjqA-4h1gA:undetectable","3zjqA-4h1gA:15.33"],["3ZJQ_B_NCAB300_0","PROTOGLOBIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"VAL A 438;PHE A 657;VAL A 419;PHE A 420;ILE A 427","None","1.13A","3zjqB-4h1gA:undetectable","3zjqB-4h1gA:15.33"],["4AX8_A_SAMA1474_1","WBDD","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",4,"ARG A 349;ASP A 432;GLU A 473;LEU A 426","None","1.40A","4ax8A-4h1gA:undetectable","4ax8A-4h1gA:21.47"],["4C9K_A_CAMA424_0","CYTOCHROME P450","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"THR A 654;THR A 641;LEU A 618;GLY A 619;VAL A 633","None","1.28A","4c9kA-4h1gA:undetectable","4c9kA-4h1gA:21.70"],["4C9P_A_CAMA423_0","CYTOCHROME P450","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"THR A 654;THR A 641;LEU A 618;GLY A 619;VAL A 633","None","1.34A","4c9pA-4h1gA:undetectable","4c9pA-4h1gA:21.57"],["4DFR_B_MTXB162_1","DIHYDROFOLATE REDUCTASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"ILE A 490;ALA A 590;LEU A 618;LEU A 644;ILE A 564","None","1.08A","4dfrB-4h1gA:undetectable","4dfrB-4h1gA:13.06"],["4K39_A_SAMA504_0","ANAEROBIC SULFATASE-MATURATING ENZYME","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"PHE A 565;ASN A 435;SER A 430;LEU A 431;ILE A 467","None","1.33A","4k39A-4h1gA:undetectable","4k39A-4h1gA:19.69"],["4LF7_A_PARA1817_1","16S RRNA;RIBOSOMAL PROTEIN S9;RIBOSOMAL PROTEIN S10","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",3,"TYR A -29;ARG A-304;SER A -33","MTT A 701 (-4.6A);MTT A 701 (-3.8A);None","1.11A","4lf7I-4h1gA:undetectable;4lf7J-4h1gA:undetectable","4lf7I-4h1gA:10.81;4lf7J-4h1gA:9.55"],["4LF8_A_PARA1817_1","16S RRNA;RIBOSOMAL PROTEIN S9;RIBOSOMAL PROTEIN S10","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",3,"TYR A -29;ARG A-304;SER A -33","MTT A 701 (-4.6A);MTT A 701 (-3.8A);None","1.11A","4lf8I-4h1gA:undetectable;4lf8J-4h1gA:undetectable","4lf8I-4h1gA:10.81;4lf8J-4h1gA:9.55"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",4,"ASN A-103;ALA A-319;GLY A-314;ASP A-356","None;None;None;MTT A 701 (-2.9A)","0.97A","4n48A-4h1gA:undetectable","4n48A-4h1gA:21.35"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"ALA A-106;ALA A-265;LEU A-267;LEU A-108;VAL A-109","None","1.11A","4or0B-4h1gA:undetectable","4or0B-4h1gA:22.24"],["5JH7_B_6K9B503_1","TUBULIN ALPHA-1B CHAIN;TUBULIN BETA-2B CHAIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",4,"GLU A 422;ASN A 626;ILE A 622;VAL A 350","None","0.96A","5jh7C-4h1gA:undetectable","5jh7C-4h1gA:20.22"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"GLN A-321;ALA A-101;GLY A-316;THR A-317;ALA A-318","None","1.18A","5l66H-4h1gA:undetectable;5l66I-4h1gA:undetectable","5l66H-4h1gA:15.17;5l66I-4h1gA:15.18"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",5,"GLN A-321;ALA A-101;GLY A-316;THR A-317;ALA A-318","None","1.18A","5l66V-4h1gA:undetectable;5l66W-4h1gA:undetectable","5l66V-4h1gA:15.17;5l66W-4h1gA:15.18"],["5M0O_C_EPAC502_1","TERMINAL OLEFIN-FORMING FATTY ACID DECARBOXYLASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Candida albicans;Escherichia coli",4,"ILE A 530;PRO A 533;ALA A 536;PHE A 565","None","0.70A","5m0oC-4h1gA:undetectable","5m0oC-4h1gA:20.03"],["6B58_A_ACTA603_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",3,"TYR A-215;ASN A-143;LEU A-257","MTT A 701 (-3.8A);None;None","0.79A","6b58A-4h1gA:undetectable","6b58A-4h1gA:22.25"],["6BM5_A_SAMA1301_0","METHIONINE SYNTHASE","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"PRO A-237;GLU A-240;PRO A-116;ALA A-207;PRO A-211","None","1.42A","6bm5A-4h1gA:undetectable","6bm5A-4h1gA:19.18"],["6ECX_A_SAMA1301_0","STIE PROTEIN","4h1g","MALTOSE BINDING PROTEIN-CAKAR3 MOTOR DOMAIN FUSION PROTEIN","Escherichia coli;Candida albicans",5,"LEU A -95;GLY A-346;VAL A-335;LEU A-363;ILE A-361","None","1.00A","6ecxA-4h1gA:undetectable","6ecxA-4h1gA:17.49"]]